- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-29
DOI
10.1038/s41584-018-0091-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling
- (2018) Wida Razawy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The positive effects of secreting cytokines IL-17 and IFN-γ on the early-stage differentiation and negative effects on the calcification of primary osteoblasts in vitro
- (2018) Zhongxiu Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
- (2018) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study
- (2018) Elizabeth G. Araujo et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism
- (2018) Barbara Lisowska et al. Drug Design Development and Therapy
- Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis
- (2018) Lu Yang et al. Arthritis & Rheumatology
- Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis
- (2018) Annika Reinhardt et al. Frontiers in Immunology
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- Pathogenesis of ankylosing spondylitis — recent advances and future directions
- (2017) Vidya Ranganathan et al. Nature Reviews Rheumatology
- Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis
- (2017) Richard J. Cuthbert et al. Arthritis & Rheumatology
- Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
- (2016) Jürgen Braun et al. ANNALS OF THE RHEUMATIC DISEASES
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
- (2016) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis
- (2016) Jacek Karczewski et al. AUTOIMMUNITY
- Proinflammatory T cells and IL-17 stimulate osteoblast differentiation
- (2016) Michiel Croes et al. BONE
- The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
- (2016) Xinyang Song et al. Cellular & Molecular Immunology
- Presence of HLA-B27 is associated with changes of serum levels of mediators of the Wnt and hedgehog pathway
- (2016) Sarah Aschermann et al. JOINT BONE SPINE
- Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
- (2016) René Pfeifle et al. NATURE IMMUNOLOGY
- Chronic skin inflammation leads to bone loss by IL-17–mediated inhibition of Wnt signaling in osteoblasts
- (2016) Özge Uluçkan et al. Science Translational Medicine
- Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis
- (2016) Désirée van der Heijde et al. Arthritis & Rheumatology
- Th17 Cytokines Regulate Osteoclastogenesis in Rheumatoid Arthritis
- (2015) Kyoung-Woon Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients withRheumatoId arthritis on methotrexate toValidate inhibitory effect on boneErosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
- (2015) Tsutomu Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis
- (2015) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation
- (2015) Lynett Danks et al. ANNALS OF THE RHEUMATIC DISEASES
- Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice
- (2015) Elisa Montaldo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients
- (2015) Roland Kocijan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss
- (2015) Ulrike Harre et al. Nature Communications
- Integrated Genomics Identifies Convergence of Ankylosing Spondylitis with Global Immune Mediated Disease Pathways
- (2015) Mohammed Uddin et al. Scientific Reports
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17 inhibits osteoblast differentiation and bone regeneration in rat
- (2014) Yong-Gun Kim et al. ARCHIVES OF ORAL BIOLOGY
- Interleukin-17 is a critical target for the treatment of ankylosing enthesitis and psoriasis-like dermatitis in mice
- (2014) Shin Ebihara et al. AUTOIMMUNITY
- Cellular sources of IL-17 in psoriasis: a paradigm shift?
- (2014) Romy R. M. C. Keijsers et al. EXPERIMENTAL DERMATOLOGY
- IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice
- (2014) J. M. W. Quinn et al. JOURNAL OF IMMUNOLOGY
- IL-23 Induces Receptor Activator of NF- B Ligand Expression on CD4+ T Cells and Promotes Osteoclastogenesis in an Autoimmune Arthritis Model
- (2014) J. H. Ju et al. JOURNAL OF IMMUNOLOGY
- Crosstalk among IL-23 and DNAX Activating Protein of 12 kDa–Dependent Pathways Promotes Osteoclastogenesis
- (2014) Hyun-Seock Shin et al. JOURNAL OF IMMUNOLOGY
- Ankylosing enthesitis associated with up-regulated IFN-γ and IL-17 production in (BXSB × NZB) F1 male mice: a new mouse model
- (2014) Yasuharu Abe et al. Modern Rheumatology
- Genetic and epigenetic fine mapping of causal autoimmune disease variants
- (2014) Kyle Kai-How Farh et al. NATURE
- Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
- (2013) Arnd Kleyer et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases
- (2013) Youngkyun Lee BMB Reports
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
- (2013) Chuan Wu et al. NATURE
- Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
- (2013) Noriko Komatsu et al. NATURE MEDICINE
- Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2-microglobulin-transgenic rat model of spondylarthritis
- (2012) Leonie M. van Duivenvoorde et al. ARTHRITIS AND RHEUMATISM
- Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis
- (2012) Lotta Utriainen et al. ARTHRITIS AND RHEUMATISM
- IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner
- (2012) Carl J. DeSelm et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
- (2012) Ulrike Harre et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors
- (2012) Iannis E Adamopoulos et al. ARTHRITIS RESEARCH & THERAPY
- Functional role of IL-22 in psoriatic arthritis
- (2012) Anupam Mitra et al. ARTHRITIS RESEARCH & THERAPY
- Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
- (2012) Raquel Celis et al. ARTHRITIS RESEARCH & THERAPY
- Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis
- (2011) Tony J. Kenna et al. ARTHRITIS AND RHEUMATISM
- Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts
- (2011) Kyoung-Woon Kim et al. ARTHRITIS AND RHEUMATISM
- Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formationin Vitro
- (2011) Hasnawati Saleh et al. ENDOCRINOLOGY
- Th17 Cells, Not IL-17+ T Cells, Drive Arthritic Bone Destruction in Mice and Humans
- (2011) B. Pollinger et al. JOURNAL OF IMMUNOLOGY
- IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass
- (2011) I. E. Adamopoulos et al. JOURNAL OF IMMUNOLOGY
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses
- (2011) R. Sarin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
- (2011) Heiner Appel et al. ARTHRITIS RESEARCH & THERAPY
- Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis
- (2010) Yang Mei et al. CLINICAL RHEUMATOLOGY
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis
- (2009) Hui Shen et al. ARTHRITIS AND RHEUMATISM
- Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis
- (2009) Heiner Appel et al. ARTHRITIS AND RHEUMATISM
- IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling
- (2009) H Huang et al. CELL DEATH AND DIFFERENTIATION
- A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
- (2009) Jaya Goswami et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-23 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-κB signal pathways
- (2009) Xia Li et al. IMMUNOLOGY LETTERS
- Osteoblast Function Is Compromised at Sites of Focal Bone Erosion in Inflammatory Arthritis
- (2009) Nicole C Walsh et al. JOURNAL OF BONE AND MINERAL RESEARCH
- IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-α antibody: A novel mechanism of osteoclastogenesis by IL-17
- (2009) Toru Yago et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine
- (2008) R Landewe et al. ANNALS OF THE RHEUMATIC DISEASES
- Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
- (2008) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Review: Immune cells and mediators of inflammatory arthritis
- (2008) Georg Schett AUTOIMMUNITY
- IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-κB (RANK) expression in myeloid precursor cells
- (2008) Li Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Genetic Variants of the IL-23R Pathway: Association with Psoriatic Arthritis and Psoriasis Vulgaris, but No Specific Risk Factor for Arthritis
- (2008) Ulrike Hüffmeier et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now